InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Dayno Jeffrey M., Directeur Médical. Officer active across 2 companies, notably Harmony Biosciences Holdings, Inc.. In total, 13 filings have been published. Split: 0 buy · 1 sell. History available since 22 July 2021. The latest transaction was disclosed on 24 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Dayno Jeffrey M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
10,500 股0Common StockSEC:0001615993-26-000002:0
20,000 股@ US$8.2217.3% 占其流量Common StockSEC:0001615993-25-000005:0
10,500 股0Common StockSEC:0001415889-25-002159:0
19,293 股@ US$8.2216.2% 占其流量Common StockSEC:0001415889-25-001931:0
15,000 股@ US$8.2213.4% 占其流量Common StockSEC:0001415889-22-011083:0
15,000 股@ US$8.2213.3% 占其流量Common StockSEC:0001415889-22-010986:0
14,099 股@ US$8.2212.3% 占其流量Common StockSEC:0001104659-21-128203:0
1,800 股@ US$8.221.6% 占其流量Common StockSEC:0001104659-21-124273:0
10,000 股@ US$8.228.6% 占其流量Common StockSEC:0000899243-21-035505:0
2,159 股@ US$8.221.9% 占其流量Common StockSEC:0000899243-21-034517:0
9,950 股@ US$8.228.6% 占其流量Common StockSEC:0000899243-21-032526:0
50 股@ US$8.220.0% 占其流量Common StockSEC:0000899243-21-029687:0
536 股Common StockSEC:0001179110-16-017045:0
13 条申报中的 13 条
About Dayno Jeffrey M.
Dayno Jeffrey M. is Chief Medical Officer. He has 13 filings in total, and the 13 sampled filings cover the period from 2016-01-05 to 2026-01-26, with the modal transaction nature shown as option exercise.
